These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 3126032)

  • 1. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Orth DN; Peterson ME; Drucker WD
    Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
    Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
    Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Oct; 33(5):713-9. PubMed ID: 3030713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
    J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
    Orth DN; Nicholson WE
    Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential secretion of pro-opiomelanocortin peptides by the pars distalis and pars intermedia of beagle dogs.
    Kemppainen RJ; Sartin JL
    J Endocrinol; 1988 Apr; 117(1):91-6. PubMed ID: 2833553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of proopiomelanocortin messenger ribonucleic acid in the pars distalis and pars intermedia of the pituitary gland after prolonged hypoxemia in fetal sheep.
    Braems GA; Matthews SG; Challis JR
    Endocrinology; 1996 Jul; 137(7):2731-8. PubMed ID: 8770892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of various parameters in the differential diagnosis of Cushing's disease and Cushing's syndrome caused by adrenal adenoma].
    Lu ZL; Zhang GX; Liu W
    Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):28-31, 62. PubMed ID: 2737034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.